Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Agenus's profit margin for the twelve months ending Dec 31, 2020 was -207.4%. For fiscal 2017 it was -281.5%, against -562.6% the year before. The highest annual figure on record is -71.0% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -281.5% | +281.1 |
| FY2016 | Dec 31, 2016 | -562.6% | −208.5 |
| FY2015 | Dec 31, 2015 | -354.1% | +254.8 |
| FY2014 | Dec 31, 2014 | -608.9% | +378.6 |
| FY2013 | Dec 31, 2013 | -987.5% | −916.6 |
| FY2012 | Dec 31, 2012 | -71.0% | +773.7 |
| FY2011 | Dec 31, 2011 | -844.6% | −192.6 |
| FY2010 | Dec 31, 2010 | -652.0% | +257.2 |
| FY2009 | Dec 31, 2009 | -909.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -120.7% | −31.3 |
| Q3 FY2020 | Sep 30, 2020 | -348.2% | −116.1 |
| Q2 FY2020 | Jun 30, 2020 | -179.0% | +151.0 |
| Q1 FY2020 | Mar 31, 2020 | -299.3% | −321.1 |
| Q4 FY2019 | Dec 31, 2019 | -89.4% | +667.8 |
| Q3 FY2019 | Sep 30, 2019 | -232.1% | +31.4 |
| Q2 FY2019 | Jun 30, 2019 | -330.0% | −171.5 |
| Q1 FY2019 | Mar 31, 2019 | 21.8% | +3338.5 |
| Q4 FY2018 | Dec 31, 2018 | -757.2% | −337.8 |
| Q3 FY2018 | Sep 30, 2018 | -263.5% | +833.3 |
| Q2 FY2018 | Jun 30, 2018 | -158.6% | +595.1 |
| Q1 FY2018 | Mar 31, 2018 | -3316.7% | −3253.2 |
| Q4 FY2017 | Dec 31, 2017 | -419.4% | +49.1 |
| Q3 FY2017 | Sep 30, 2017 | -1096.8% | −179.7 |
| Q2 FY2017 | Jun 30, 2017 | -753.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -63.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -468.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -917.1% | – |
See a number that looks wrong?